• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Piramal Pharma Limited — Important, 28-01-2026: Arrangements for strategic, technical, manufacturing, or marketing tie up

    28-01-2026 | 11:57 pm

    Piramal Pharma's subsidiary acquired Kenalog® brands from Bristol-Myers Squibb for US$35 million upfront, plus up to US$65 million contingent. This expands PPL's CHG portfolio, leveraging global distribution for future growth in US, Europe, and Asia Pacific.

    No comments yet. Be the first to comment!

    All announcements from Piramal Pharma Limited